BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL, Qu YQ. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Front Cell Dev Biol 2021;9:682002. [PMID: 34409029 DOI: 10.3389/fcell.2021.682002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Sun Z, Lu S, Zhang X, Xiao C, Li T, Wu J. Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma. Front Oncol 2022;12:834524. [DOI: 10.3389/fonc.2022.834524] [Reference Citation Analysis]
2 Gu H, Song J, Chen Y, Wang Y, Tan X, Zhao H. Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma. Front Oncol 2022;12:923641. [PMID: 35719911 DOI: 10.3389/fonc.2022.923641] [Reference Citation Analysis]
3 Cai W, Jing M, Wen J, Guo H, Xue Z. Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. Front Genet 2022;13:817552. [PMID: 35711943 DOI: 10.3389/fgene.2022.817552] [Reference Citation Analysis]
4 Wang B, Liu L, Wu J, Mao X, Fang Z, Chen Y, Li W. Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma. Front Genet 2022;13:711142. [DOI: 10.3389/fgene.2022.711142] [Reference Citation Analysis]
5 Chen Q, Yang S, Zhang Y, Li B, Xu H, Zuo S, Yang Z. Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/9868022] [Reference Citation Analysis]
6 Yi J, Zhong W, Wu H, Feng J, Zouxu X, Huang X, Li S, Shuang Z. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer. Front Oncol 2021;11:746058. [PMID: 34745969 DOI: 10.3389/fonc.2021.746058] [Reference Citation Analysis]